Agilent Technologies (A) vs Alamar Biosciences (ALMR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Agilent Technologies is the larger company by market cap ($47.42 billion vs $1.80 billion), about 26.4 times the size. Agilent Technologies pays a dividend yielding 0.60%, while Alamar Biosciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | ALMR |
|---|---|---|
| Share price | $168.17 | $25.91 |
| Market cap | $47.42B | $1.80B |
| 1-day change | -0.54% | -6.70% |
| YTD return | +24.27% | — |
| 1-year return | +22.03% | — |
| 5-year return | +10.32% | — |
| P/E ratio (TTM) | 33.17 | — |
| Forward P/E | 24.88 | — |
| EPS (TTM) | $5.07 | $-1.20 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $1.01 | $0.00 |
| Revenue (latest FY) | $6.95B | — |
| Revenue growth (YoY) | +6.73% | — |
| Net income (latest FY) | $1.30B | — |
| Gross margin | 52.43% | — |
| Operating margin | 21.29% | — |
| Net margin | 18.75% | — |
| 52-week high | $177.05 | $39.61 |
| 52-week low | $108.35 | $18.85 |
| Distance from 52-week high | -5.02% | -34.59% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +4.95% | +36.63% |
| Average volume | 2.26M | 399.23K |
| Shares outstanding | 281.97M | 69.39M |
| Employees | 18,200 | 286 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is about 26.4 times larger than Alamar Biosciences by market value ($47.42B vs $1.80B).
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
A vs ALMR FAQ
Which is bigger, Agilent Technologies or Alamar Biosciences?
Agilent Technologies (A) is larger, with a market capitalization of $47.42B compared with $1.80B for Alamar Biosciences (ALMR).
Which pays a higher dividend, Agilent Technologies or Alamar Biosciences?
Agilent Technologies pays a dividend yielding 0.60%, while Alamar Biosciences does not currently pay a regular dividend.
Are Agilent Technologies and Alamar Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.